These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6782535)

  • 1. [Assessment of the clinical usefulness of the preparation Mesna (Mucofluid, Mistabron) produced by UCB in treatment of certain laryngological diseases (author's transl)].
    Semczuk B; Gołabek W; Kłos A; Horoch A; Siwiec H; Kupisz K
    Otolaryngol Pol; 1980; 34(6):553-8. PubMed ID: 6782535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aerosol therapy with Mesna in pneumology (Mistabron ucb) (author's translation)].
    Goossens E
    Acta Tuberc Pneumol Belg; 1976; 67(3-4):200-6. PubMed ID: 827936
    [No Abstract]   [Full Text] [Related]  

  • 3. Mistabron in the intensive care unit.
    Van De Walle J; Lauwers P; Adriaensen H
    Acta Anaesthesiol Belg; 1976; 27 suppl():319-21. PubMed ID: 827913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Double contrast studies of the colon. Use of acetyl-cystein or mucofluid? (author's transl)].
    Timon-David P; Vanelle P; Fournier AM
    J Radiol; 1979 Dec; 60(12):797-8. PubMed ID: 119048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro assessment of combined antibiotic and mucolytic treatment for Pseudomonas aeruginosa infection in cystic fibrosis.
    Heaf DP; Webb GJ; Matthew DJ
    Arch Dis Child; 1983 Oct; 58(10):824-6. PubMed ID: 6416185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis.
    Weller PH; Ingram D; Preece MA; Matthew DJ
    Thorax; 1980 Jan; 35(1):42-6. PubMed ID: 6767295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Controlled evaluation of a Mistabron treatment in patients with chronic bronchitis (author's transl)].
    Toussaint C
    Acta Tuberc Pneumol Belg; 1975; 66(4-5):434-9. PubMed ID: 1225051
    [No Abstract]   [Full Text] [Related]  

  • 8. Mesna and false-positive results in ward testing for urinary ketones.
    Gordon-Smith EC; Hows JM; Ward L; Woods K; Dalton JI
    Lancet; 1982 Mar; 1(8271):563. PubMed ID: 6120415
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of urinary tract toxicity of oxazaphosphorines by a "uroprotector". Report on a field study (author's transl)].
    Burkert H; Schnitker J; Fichtner E
    MMW Munch Med Wochenschr; 1979 Jun; 121(22):760-2. PubMed ID: 112422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of ifosfamide/mesna in metastatic adult renal carcinoma.
    De Forges A; Droz JP; Ghosn M; Theodore C
    Cancer Treat Rep; 1987 Nov; 71(11):1103. PubMed ID: 3119203
    [No Abstract]   [Full Text] [Related]  

  • 11. Ifosfamide and Mesna in advanced malignancies.
    Li GC; Brock N; Li JQ; Guan ZZ; He YJ
    Chin Med J (Engl); 1988 Mar; 101(3):213-20. PubMed ID: 3136996
    [No Abstract]   [Full Text] [Related]  

  • 12. Action of a mucolytic in the first 72 hours after abdominal surgery. Concerning 34 patients with respiratory insufficiency.
    Devaux C; Bagot C; Chouckroun J
    Acta Anaesthesiol Belg; 1980; 31 Suppl():137-46. PubMed ID: 6779493
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of mucolytic and bronchodilator aerosol therapy on airway resistance in mechanically ventilated patients.
    Zandstra DF; Stoutenbeek CP; Miranda DR
    Intensive Care Med; 1985; 11(6):316-8. PubMed ID: 3936867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benzylamines and their homologues in the treatment of diseases of the ear, nose and throat (author's transl)].
    Renovanz HD; Papendick U; von Seefeld H
    MMW Munch Med Wochenschr; 1974 Jan; 116(2):63-8. PubMed ID: 4205576
    [No Abstract]   [Full Text] [Related]  

  • 15. Mistabron effects on platelets and blood coagulation.
    Henry RL; Washnock MA; Taylor GW
    J Int Med Res; 1984; 12(5):277-80. PubMed ID: 6437891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative investigation on sputum viscosity before and after administration of mistabron or physiological saline solution with and without physiotherapy (vibration-therapy) (author's transl)].
    Maesen F; Brombacher PJ; Buytendijk HJ; Janssen HC
    Acta Tuberc Pneumol Belg; 1974; 65(2):212-8. PubMed ID: 4371451
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mistabron, a new mucolytic (author's transl)].
    Van De Walle J
    Acta Tuberc Pneumol Belg; 1974; 65(5):505-19. PubMed ID: 4466342
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical studies on the mucolytic effect of mesna.
    Tekeres M; Horváth A; Bárdosi L; Kenyeres P
    Clin Ther; 1981; 4(1):56-60. PubMed ID: 6791825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesna and bone-marrow transplantation.
    Becher R; Kakati S; Sandberg AA
    N Engl J Med; 1982 Oct; 307(18):1152. PubMed ID: 6811895
    [No Abstract]   [Full Text] [Related]  

  • 20. [Usefulness of 2-mercaptoethanol sodium sulfonate (Mesnum) in the prevention of hemorrhagic cystitis in patients undergoing bone marrow transplantation].
    Grañena A; Gardella S; Marín P; Carreras E; Montserrat E; Rozman C
    Sangre (Barc); 1986; 31(3):307-10. PubMed ID: 3092373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.